1. Home
  2. ALGS vs SAEN Comparison

ALGS vs SAEN Comparison

Compare ALGS & SAEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

N/A

Current Price

$2.11

Market Cap

34.6M

Sector

Health Care

ML Signal

N/A

SAEN

Genenta Science S.p.A. American Depositary Shares

N/A

Current Price

$0.70

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALGS
SAEN
Founded
2018
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
28.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ALGS
SAEN
Price
$2.11
$0.70
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $36.88
N/A
AVG Volume (30 Days)
★ 55.4K
20.5K
Earning Date
11-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 88.30
N/A
EPS
N/A
★ N/A
Revenue
★ $2,186,000.00
N/A
Revenue This Year
$1,433.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.02
$0.63
52 Week High
$13.69
$0.75

Technical Indicators

Market Signals
Indicator
ALGS
SAEN
Relative Strength Index (RSI) 18.06 N/A
Support Level N/A N/A
Resistance Level $7.79 N/A
Average True Range (ATR) 0.55 0.00
MACD -0.29 0.00
Stochastic Oscillator 1.45 0.00

Price Performance

Historical Comparison
ALGS
SAEN

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: